Joseph Cheatle, MD
Neurological Surgery · Charlotte, NCNPI 1093976995
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,200 of the $44,465 with a category attached, or 72.4%. Boston Scientific accounts for 93.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $26,965 and has fallen 52.0% since, to $12,944 in 2025.
Across 207 payments — averaging $214.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$42K
- Globus Medical$2K
- Nevro Corp.$344
- Medtronic$154
- Abbott$85
- Aesculap, Inc.$45
- plus $50 from 3 others
Across 2 payments — averaging $1025.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$2K
What the payments were for
- Speaking & faculty fees$32,20072%
- Travel & lodging$5,18112%
- Food & beverage$7,08516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 175 | $41,549 |
| Globus Medical(2 entities) | 16 | $2,240 |
| Nevro Corp. | 5 | $344 |
| Medtronic(2 entities) | 4 | $154 |
| Abbott | 2 | $85 |
| Aesculap, Inc. | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $19 |
| Convatec Inc. | 1 | $15 |
| Theragen, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,465 in reported general payments places this provider in the 75th percentile of 196 neurological surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 103 | $1,041 |
| Meloxicam | 51 | $232 |
| Methylprednisolone | 33 | $219 |
| Methocarbamol | 22 | $204 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $186 |
| Tizanidine Hcl | 19 | $101 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $86 |
| Tramadol Hcl | 28 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $64 |
| Diazepam | 24 | $34 |
| Cyclobenzaprine Hcl | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Charlotte
- Domagoj CoricCharlotte$2.3M
- Paul KimCharlotte$1.5M
- Matthew McGirtCharlotte$693K
- Tim AdamsonCharlotte$470K
- Michael BohlCharlotte$120K
- Vincent RossiCharlotte$104K
- Joe BernardCharlotte$101K
- Andrew HealyCharlotte$99K
- Anthony AsherCharlotte$93K
- Frederick FingerCharlotte$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.